Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
United Therapeutics Insider Sold Shares Worth $5,650,415, According to a Recent SEC Filing

United Therapeutics Insider Sold Shares Worth $5,650,415, According to a Recent SEC Filing

MT newswireMT newswire2026/10/30 20:39
04:39 PM EDT, 10/30/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on October 29, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,650,415. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000175/xslF345X05/primarydocument.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Meta (META.US) AI shopping assistant Muse tests e-commerce, Amazon (AMZN.US) faces potential impact on nearly $70 billion advertising business

Meta Platforms (META.US) has launched its new AI shopping assistant, Muse, which is emerging as a potential threat to Amazon. Muse may challenge the e-commerce giant’s dominance in online shopping and its nearly 70 billion USD advertising business.

智通财经•2026/11/01 23:16
Meta (META.US) AI shopping assistant Muse tests e-commerce, Amazon (AMZN.US) faces potential impact on nearly $70 billion advertising business